SANOFI US SERVICES INC. for SANOFI US SERVICES INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 18, 2013 | $1,800,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jul 18, 2013 | $1,800,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Economics/Economic Development ECN
General issues related to foreign direct investment in the United States.
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Taxation/Internal Revenue Code TAX
Extension of the U.S. R&D tax credit; adding quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
General issues related to settlements of patent infringement litigation; international intellectual property issues.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Health Issues HCR
S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Medicare/Medicaid MMM
Issues related to changes to the Medicare Part B reimbursement of prescription drugs; issues related to coverage and reimbursement for those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; and general issues related to the Medicare Part D program.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Animals ANI
Education and awareness regarding illegal compounding of veterinary drugs for animals; general issues related to the reauthorization of the Animal Drug User Fee Act; HR1150 "Preservation of Antibiotics for Medical Treatment Act of 2013"; HR820 "Delivering Antimicrobial Transparency in Animals Act of 2013."
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SANOFI PASTEUR | Swiftwater, PA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.